stella
beta
Efficacy and Safety of Sintilimab Combined With Lenvatinib and HAIC for Neoadjuvant Therapy of Borderline Resectable HCC — Stella
Home
/
HCC
/
View on ClinicalTrials.gov
Recruiting
Back to HCC trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
Shandong Cancer Hospital and Institute, Jinan, Shandong